Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole vs Esomeprazole for Prevention of Stress Ulcer Bleeding
NCT05841394Phase 3Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Jul 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ilaprazole in stress ulcer (2 arms), sponsored by Livzon Pharmaceutical Group Inc. Primary endpoint: Preventing clinically significant gastrointestinal bleeding. Started Jul 2021; status: completed.
02
Drugs
ilaprazole
03
Conditions
stress ulcer
Beyond the preview
Go deeper on NCT05841394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05841394.